AR HB1881 | 2021 | 93rd General Assembly
Status
Completed Legislative Action
Spectrum: Bipartisan Bill
Status: Passed on May 3 2021 - 100% progression
Action: 2021-05-03 - Notification that HB1881 is now Act 1103
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Bipartisan Bill
Status: Passed on May 3 2021 - 100% progression
Action: 2021-05-03 - Notification that HB1881 is now Act 1103
Text: Latest bill text (Chaptered) [PDF]
Summary
To Establish The 340b Drug Pricing Nondiscrimination Act.
Title
To Establish The 340b Drug Pricing Nondiscrimination Act.
Sponsors
Rep. Michelle Gray [R] | Sen. Jason Rapert [R] | Rep. Jeff Wardlaw [R] | Sen. Reginald Murdock [D] |
Rep. Vivian Flowers [D] |
Roll Calls
2021-04-27 - Senate - Third Reading (Y: 35 N: 0 NV: 0 Abs: 0) [PASS]
2021-04-20 - House - Third Reading (Y: 65 N: 14 NV: 21 Abs: 0) [PASS]
2021-04-20 - House - Third Reading (Y: 65 N: 14 NV: 21 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2021-05-03 | House | Notification that HB1881 is now Act 1103 |
2021-04-28 | House | Correctly enrolled and ordered transmitted to the Governor's Office. |
2021-04-27 | House | TO BE ENROLLED |
2021-04-27 | House | Returned From the Senate as passed. |
2021-04-27 | Senate | Returned to the House as passed. |
2021-04-27 | Senate | Read the third time and passed. |
2021-04-26 | Senate | Returned by the Committee, with the recommendation that it Do Pass |
2021-04-20 | Senate | Read first time, rules suspended, read second time, referred to INSURANCE & COMMERCE - SENATE |
2021-04-20 | Senate | Received from the House. |
2021-04-20 | House | Read the third time and passed and ordered transmitted to the Senate. |
2021-04-15 | House | REPORTED CORRECTLY ENGROSSED |
2021-04-15 | House | Amendment No. 1 read and adopted and the bill ordered engrossed. |
2021-04-15 | House | Placed on second reading for the purpose of amendment. |
2021-04-14 | House | Returned by the Committee with the recommendation that it do pass as amended 1 |
2021-04-06 | House | Read the first time, rules suspended, read the second time and referred to the Committee on INSURANCE & COMMERCE- HOUSE |
2021-04-06 | House | Filed |